Evommune, Inc. — Quarterly Financial Statements (NYSE:EVMN) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 40.08 M
Employee 45
Founded 2020
CEO N/A
Website www.evommune.com
Headquarter Delaware, United States
FIGI BBG00Y79N887
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

40.08 M Market capitalization

Price to earnings ratio

—

Price to sales ratio

—

Dividends per share

—

Dividend yield %

—